Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition

Anticancer Properties of Zoledronic Acid

(2010) Jonathan Green et al.   CANCER INVESTIGATION

Bisphosphonates as Anticancer Therapy for Early Breast Cancer

(2010) Reshma Mahtani et al.   Clinical Breast Cancer

Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice

(2010) Takashi Kikuiri et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The impact of bisphosphonates on the osteoblast proliferation and Collagen gene expression in vitro

(2010) Felix Peter Koch et al.   Head & Face Medicine

Zoledronic acid decreases bone formation without causing osteocyte death in mice

(2009) S.S. Huja et al.   ARCHIVES OF ORAL BIOLOGY

Pulse treatment with zoledronic acid causes sustained commitment of bone marrow derived mesenchymal stem cells for osteogenic differentiation

(2009) Regina Ebert et al.   BONE

High-Dose Zoledronic Acid Impacts Bone Remodeling with Effects on Osteoblastic Lineage and Bone Mechanical Properties

(2009) S. Pozzi et al.   CLINICAL CANCER RESEARCH

Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice

(2009) Yasuyoshi Kobayashi et al.   JOURNAL OF BONE AND MINERAL METABOLISM

A novel bioassay model to determine clinically significant bisphosphonate levels

(2009) Mark A. Scheper et al.   SUPPORTIVE CARE IN CANCER

Inhibition of osteoblast function in vitro by aminobisphosphonates

(2008) Isabel R. Orriss et al.   JOURNAL OF CELLULAR BIOCHEMISTRY